1.
Frisch A, Krayem B, Zuckerman T, Henig I, Yehudai-Ofir D, Glaubach N. Intensive induction therapy with FLAG-idarubicinvenetoclax for fit older high-risk patients with acute myeloid leukemia. haematol [Internet]. 2026Aug.1 [cited 2026Aug.19];111(8):2848-51. Available from: https://haematologica.org/article/view/13380